Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viegi, G.
Right arrow Articles by Giuntini, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viegi, G.
Right arrow Articles by Giuntini, C.
(Chest. 2000;117:339S-345S.)
© 2000 American College of Chest Physicians

Prevalence of Airways Obstruction in a General Population*

European Respiratory Society vs American Thoracic Society Definition

Giovanni Viegi, MD; Marzia Pedreschi, MD; Francesco Pistelli, MD; Francesco Di Pede, BS; Sandra Baldacci, BS; Laura Carrozzi, MD and Carlo Giuntini, MD, FCCP

* From the CNR Institute of Clinical Physiology (Drs. Viegi, Pedreschi, and Ms. Baldacci), Pulmonary Environmental Epidemiology Group Pisa; and Cardiopulmonary Department (Drs. Pistelli, Carrozzi, Giuntini, and Mr. DiPede), University and Hospital of Pisa, Italy.

Correspondence to: Giovanni Viegi, MD, CNR Institute of Clinical Physiology, Via Trieste 41, 56126 Pisa, Italy; e-mail: viegig{at}ifc.pi.cnr.it


    Abstract
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Study objectives: To evaluate the distribution of airways obstruction in a general population sample.

Methods: Cross-sectional epidemiologic survey of a general population sample living in Po Delta area (North Italy). Data on respiratory symptoms, diseases, and risk factors were collected through standardized interviewer-administered questionnaires. Lung function tests were performed, with criteria for defining airways obstruction based on the 1995 European Respiratory Society (ERS) statement (FEV1/vital capacity ratio < 88% predicted and < 89% predicted in men and women, respectively), "clinical" criteria (FEV1/FVC ratio < 70%), and the 1986 American Thoracic Society (ATS) statement (FEV1/FVC ratio < 75%).

Results: A total of 1,727 subjects aged > 25 years investigated from 1988 to 1991 were included. Prevalence rates of airways obstruction for subjects 25 to 45 years old and subjects >= 46 years old were as follows: ERS, 10.8% and 12.2%; clinical, 9.9% and 28.8%; and ATS, 27% and 57%, respectively. When considering only moderate/severe obstruction, the rates were as follows: ERS, 0.4% and 3.6%; clinical, 0.3% and 4.4%; and ATS, 0.5% and 5.2%, respectively. The trend was confirmed after stratifying for smoking habit and the presence/absence of respiratory symptoms/diseases. The highest specificity and predictive value for any respiratory symptom/disease was shown by the ERS, and the lowest was shown by the ATS criterion, while the reverse was true for sensitivity; overall accuracy was slightly lower for the ATS criterion. Multiple logistic regression models indicated a higher number of significant associations with known risk factors for airways obstruction according to clinical and ATS criteria than ERS criterion.

Conclusions: The prevalence of COPD in a general population depends very much on the criterion used for definition of airways obstruction. Further research is needed to reach a standardized and epidemiologically consistent criterion for airways obstruction.

Key Words: airways obstruction definition • COPD • epidemiological survey • FEV1 • FVC • general population • prevalence


    Introduction
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
In 1995, both the American Thoracic Society (ATS)1 and the European Respiratory Society (ERS)2 published statements on assessment and management of COPD. These documents have completed a process of diagnosis standardization, already begun with asthma,3 which may help in the management of noncarcinogenic respiratory disease, which takes a large toll of life in developed countries.4

An important difference between the two documents is represented by the definition of airways obstruction. The ERS document2 states that airways obstruction is present when the FEV1/slow vital capacity (VC) ratio is < 88% of the predicted value in men and < 89% predicted in women; subsequently, severity of COPD is graded on the level of reduction of percent predicted FEV1. Conversely, in the ATS document,1 the presence of airways obstruction is not numerically defined, with only the grade of COPD severity detailed. Indeed, although the practice of defining a fixed FEV1/FVC ratio as a lower limit of normal was not recommended in the 1991 ATS document,5 only in an ATS document of > 10 years ago6 is a precise definition of airways obstruction indicated (as a FEV1/FVC ratio < 75%), and this is still in use.

In clinical activities in Europe, an empirical level of 70% for FEV1/FVC is often used to define airways obstruction. The issue of an accurate definition of COPD is critical in epidemiology in order to compare findings of different surveys,7 8 9 10 but it is also important for clinical studies assessing survival11 or lung function outcomes.12 13

The aim of this study is to evaluate the distribution of COPD in terms of prevalence and severity by comparing the ERS and the ATS criteria, along with the "clinical" one, in a general population sample living in a lowly polluted area of North Italy.


    Materials and Methods
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Data for these analyses were collected from 1988 to 1991 during the second Po Delta survey (n = 2,841; age, 8 to 73 years), a cross-sectional survey of a longitudinal study carried out to assess the possible effects of a large oil-burning power plant, before and 8 years after its operation, on a general population sample living in Po Delta valley, mostly a lowly polluted rural area.14

The study has been fully described elsewhere.15 16 17 18 19 Briefly, each subject answered to the interviewer-administered standardized questionnaire on respiratory symptoms, diseases, and risk factors, elaborated by the Italian National Research Council based on that of the National Heart, Lung, and Blood Institute.16 Subjects were also invited to undergo objective methods of investigation, including VC and forced expirograms.

A computerized pneumotachograph (Pulmonary System 47804S; Hewlett-Packard; Waltham, MA) was used for the acquisition and on-line analysis of lung function data during the field survey. The system consisted of a Fleisch pneumotachograph No. 3, for flow measurements, linked via an analog-to-digital converter (47310A; Hewlett-Packard) to a 9825A calculator (Hewlett-Packard; Cupertino, CA). In this system, the pressure change, induced by the respiratory flow passing through the pneumotachograph, was translated into millivolts. The analog-to-digital converter translated measured millivolts to digits, and the computer integrated the volume signal from the flow signal. The pneumotachograph response was linear (± 3% between 1 and 12 L/s). The end point of the FVC maneuver was determined using feedback requiring consecutive samples to determine a flow < 15 mL/s, and no time limitation was imposed by the algorithm.20 The volume calibration of the pneumotachograph was performed daily with a 3.0-L standard syringe. Each subject performed at least three acceptable and reproducible FVC maneuvers, as specified by ATS protocol.21 Predicted values were computed using reference equations derived from normal subjects within the sample that took part in the first cross-sectional investigation in the Po Delta area.17

Definition of COPD was made according to the following criteria: ERS, FEV1/VC < 88% predicted in men or < 89% predicted in women2 ; "clinical," FEV1/FVC < 70%; and ATS, FEV1/FVC < 75%.6 Severity of COPD was defined as follows: ERS, mild (FEV1 >= 70% predicted), moderate (FEV1 69 to 50% predicted), or severe (FEV1 < 50% predicted)2 ; clinical, mild (FEV1 >= 70% predicted), or moderate-severe (FEV1 < 70% predicted); and ATS, mild (FEV1 100 to 70% predicted), moderate (FEV1 69 to 60% predicted), moderately severe (FEV1 59 to 50% predicted), severe (FEV1 49 to 34% predicted), or very severe (FEV1 < 34% predicted).21 With the ATS severity grading, mild, moderate, and moderately severe levels would correspond to COPD stage I, severe level to COPD stage II, and very severe level to COPD stage III.1

Subjects were considered symptomatic if they answered affirmatively to any question referring to chronic respiratory symptoms and/or diseases. In addition, subjects who reported wheeze or a medical diagnosis of asthma were considered in the analyses. Subjects who answered affirmatively to standard questions regarding chronic cough, chronic phlegm, or a diagnosis of chronic bronchitis and/or pulmonary emphysema were defined as suffering from chronic obstructive lung disease. Another category was made by those reporting dyspnea on exertion.

Nonsmokers were defined as those who never had smoked. Smokers were those who were currently smoking at least one cigarette daily. Ex-smokers included those who had formerly smoked regularly until >= 6 months before the examination.

In the logistic regression models, the following risk factors for airways obstruction were analyzed: age; height; weight; pack-years; familial history for COPD; childhood respiratory infections; work exposure to dusts/chemicals; and low socioeconomic conditions. Age was expressed in decades, height was expressed in decimeters, and weight was expressed in kilograms. Pack-years (ie, number of cigarettes smoked daily multiplied by the years of smoking divided by 20) was multiplied by 10. Childhood respiratory infections were based on whether the subject had frequent chest colds, and one or more episodes of pneumonia, croup, or pseudocroup before the age of 12 years. Low socioeconomic condition was determined on the basis of two indexes: crowding (the number of subjects living in the house divided by the number of rooms), and occupation (the percentage of those in higher occupational positions based on the official classification of the National Statistics Institute, ie, white-collar workers, self-employed, professionals, and managers). In particular, low socioeconomic conditions were characterized by the position of the subject in the upper tertile of the frequency distribution of crowding, and in the lower tertile of the frequency distribution of occupation.

Statistical analyses were performed at the Pisa University Computer Center using the Statistical Package for the Social Sciences (SPSSX; SPSS; Chicago, IL). The following analyses were applied: frequency distribution, {chi}2 test, one-way analysis of variance, and multiple logistic regression.

Sensitivity, specificity, predictive value, and overall accuracy22 of each criterion of COPD definition were assessed on the basis of presence/absence of any chronic respiratory symptom/disease.


    Results
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
No subject < 14 years old presented airways obstruction by any of the three definitions, while among those 15 to 24 years old (n = 533), there were relatively few people with airways obstruction: 11.7% by ERS criterion, 4.6% by clinical criterion, and 16.3% by ATS criterion. In addition, the proportion of subjects reporting any chronic respiratory symptom was 26%. Thus, the analyses were carried out only in those 25 to 73 years old (n = 1,727). Mean age and values of percent predicted FEV1, percent predicted FEV1/VC, and FEV1/FVC percent by gender and age group are described in Table 1 . There was no statistically significant difference by gender, with the exception of FEV1/FVC percent, which was larger in women.


View this table:
[in this window]
[in a new window]

 
Table 1.. Mean Values of Age, Percent Predicted FEV1, Percent Predicted FEV1/VC, and FEV1/FVC Percent*

 
Prevalence rates of subjects with airways obstruction by age groups, criterion of definition, and severity of COPD are depicted in Table 2 . There were no subjects with very severe levels of airways obstruction. Both in the whole sample and in the younger and older age groups, the highest prevalence rates of any abnormal level of airways obstruction were shown by the ATS criterion, and the lowest by the ERS. There was a slight difference between ERS and clinical criterion. The largest difference observed was due to the very large prevalence of mild abnormalities with the ATS criterion.


View this table:
[in this window]
[in a new window]

 
Table 2.. Prevalence of Obstructed Subjects by Age Group With Abnormal Levels of FEV1 Percent by ERS, Clinical, and ATS Criteria

 
The same trend in prevalence rates (ATS greater than clinical, clinical greater than ERS) was evident after stratification by gender, age, and smoking status (Table 3 ). The only exception was the clinical criterion in the female smokers, nonsmokers, and ex-smokers aged 25 to 45 years, and in the nonsmoking men aged 25 to 45 years, which showed lower prevalence rates of subjects with airways obstruction with the clinical compared with ERS criterion. In the subjects aged 25 to 45 years, the largest prevalence rates of airways obstruction were shown by ex-smokers, followed by smokers, with the exception of nonsmoker male subjects for ERS and nonsmoker female subjects for ATS. Moreover, in the group >= 46 years old, smokers showed the largest prevalence rates of airways obstruction for all criteria, followed by ex-smokers, with the exception of male subjects for the ERS definition. Almost all the pair comparisons (ERS vs ATS, ERS vs clinical, and clinical vs ATS) were significantly different by {chi}2 tests. A nonsignificant comparison was observed for nonsmoking men (ERS vs ATS) in subjects >= 46 years old, and borderline comparisons were noted in the ex-smoker and nonsmoker female subjects (ERS vs ATS), also in subjects >= 46 years old.


View this table:
[in this window]
[in a new window]

 
Table 3.. Prevalence of Obstructed Subjects by Sex, Age, and Smoking by ERS, Clinical, and ATS Criteria*

 
When respiratory symptoms/diseases were taken into account, those with at least one symptom, those with chronic obstructive lung disease, those with asthma or wheeze, and those with dyspnea showed larger prevalence rates of airways obstruction than those without symptoms (Table 4 ). The odds ratios (ORs) for airways obstruction ranged from 1.40 to 2.81. The same rank of criteria as seen before was found.


View this table:
[in this window]
[in a new window]

 
Table 4.. Prevalence Rates and Ratios of Obstruction Among Subjects Reporting Respiratory Symptoms/Diseases*

 
An analysis of sensitivity, specificity, predictive power, and overall accuracy of ATS, ERS, and clinical criterion with respect to presence/absence of any chronic respiratory symptom/disease (chronic cough, chronic phlegm, dyspnea [greater than grade 2], attacks of shortness of breath with wheeze or whistling, wheeze, chronic bronchitis, emphysema, asthma) was also performed. The highest specificity and positive predictive value was shown by the ERS (93% and 58%, respectively), and the lowest by ATS criterion (64% and 54%, respectively); respective values for the clinical criteria were 86% and 53%. The specificity and sensitivity of the ERS and clinical criteria were significantly (p < 0.001) greater and lower than that of the ATS, respectively. As regards sensitivity, the highest value was shown by ATS criterion and the lowest by the ERS (49% and 17% vs 26% for the clinical criteria). The same trend was shown for negative predictive value, although the differences among the criteria were slight (ATS, 68%; ERS, 65%; clinical, 66%). Moreover, the ERS and the clinical criterion had the highest overall accuracy (64% for both), while the ATS had the lowest (58%).

Multiple logistic regression analyses were performed in order to evaluate the determinants for the presence of airways obstruction by each criterion (Table 5 ). Lifetime cigarette consumption (expressed as pack-years) and childhood respiratory infections were significant risk factors for airways obstruction in both sexes according to all three criteria (except for ATS in female subjects with regard to childhood respiratory infections). Familial history for COPD was a significant risk factor in male subjects for ATS and clinical criteria, and in female subjects for ERS criterion (in the opposite direction). Age and height were significant risk factors according to both clinical and ATS criteria, but not according to ERS criterion. Work exposure to dusts/chemicals was significantly associated with airways obstruction for ATS criterion in male subjects and for clinical criterion in female subjects (in the opposite direction). Low socioeconomic condition was significantly associated with airway obstruction for ATS criterion in male subjects. Weight, familial history for asthma, and adolescence-adulthood respiratory infections did not show any significant association.


View this table:
[in this window]
[in a new window]

 
Table 5.. Significant Risk Factors for COPD Definition by Gender According to ERS, Clinical, and ATS Criteria*

 

    Discussion
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
The prevalence rate of airways obstruction in the adults of a general population sample living in a lowly polluted rural area of North Italy varies, according to the criterion used for its definition, from 11.0% with ERS to 18.3% with the clinical criterion, up to 40.4% with the ATS criterion.

The ATS criterion shows an overestimation of the prevalence of COPD, in so far as the threshold FEV1/FVC ratio for considering the presence of airways obstruction is at a very high level.6 In the 1991 ATS statement on the interpretative strategies of lung function testing,5 an obstructive ventilatory defect was defined on the basis of the reduction of FEV1/VC, without recommending a definite value for diagnosing it. Moreover, in two more recent ATS documents dealing with airways obstruction,1 23 it was not clearly stated when airways obstruction is present. Therefore, the 1986 criterion,5 which is still in use, was used in these analyses. The overestimation of airways obstruction prevalence occurs especially for the mild level with the ATS criterion, particularly in subjects >= 46 years old. This trend is present also when stratifying subjects by smoking status, or considering separately subjects without respiratory symptoms and subjects with symptoms/diagnosis of chronic bronchitis or emphysema and of asthma, or wheeze (ie, a symptom that may be present in either disease).

The ERS criterion of defining and grading COPD severity is theoretically reliable, since it takes into account the physiologic reduction of airway caliber with aging.19 On the other hand, the ERS criterion yields lower sensitivity (17%) and higher specificity and positive predicted value (93% and 58%) than both the ATS and the clinical criteria, and similar values of negative predicted value. The overall accuracy is equal for ERS and clinical criterion (64%), and higher than that of the ATS (58%). Hence, the overall accuracy of the diagnosis of COPD is, at present, rather limited. Further, no actual criterion of defining airways obstruction appears to be epidemiologically valid, at least in a general population sample characterized by a low prevalence rate of diseased subjects. These results are certainly influenced by the choice of such reported symptoms/diseases as a "gold standard" for validation of the COPD definition, since reported symptoms/diseases are scanty until the disease process is fairly advanced. However, this is an unavoidable issue in epidemiologic studies in which no direct medical evaluation or other tests (radiography, CT scan) are available.

Concerning the comparison of the prevalence rates of airways obstruction in different populations, the figures range from 0.8 to 13.2% in US studies.24 Lebowitz25 reported prevalence rates of physician-confirmed airways obstructive disease (emphysema, chronic bronchitis, or asthma) with an FEV1/FVC ratio < 75% in the general population sample of Tucson, AZ, in individuals aged 25 to 75 years; values ranged from 8 to 21% in men and from 9 to 24% in women. Beside the variance due to the characteristics of the different populations, there is a variance due to the lack of a standardized definition of airways obstruction.

With regard to the degree of severity of airways obstruction, our data show that, in a general population living in a lowly area exposed to air pollution, there are very few subjects with moderate/severe airways obstruction. One might consider that this is due to a sort of "healthy worker" effect, ie, that people with a severe disease die earlier or that they are not willing to participate in an epidemiologic study. As far as the latter issue is concerned, however, data collected by others in a different study26 show that the reverse is true, ie, people with symptoms or disease tend to participate more frequently in an epidemiologic study.

The results of logistic regression analyses confirm that important differences exist between ERS criterion and the ATS and clinical criteria. In fact, while only pack-years and childhood respiratory infections diseases are consolidated risk factors for airways obstruction according to ERS criterion, more risk factors are significantly associated with the presence of airways obstruction according to ATS and clinical criteria. These findings are in line with those obtained in the first Po Delta study,18 and might indicate that ATS and clinical criteria identify subjects with an early stage of airways obstruction. They, with the exception of the elderly, can benefit from the removal of risk factors such as smoking, occupational exposure to dusts, chemicals, or fumes, and low socioeconomic condition. Conversely, the ERS criterion would seem to identify subjects who have an established airways obstruction because they have smoked too much and have already had childhood respiratory infections.

In order to extend the process of standardization in a global view of respiratory medicine, as also discussed in the 1997 ATS Planning Retreat (personal notes; April 24–25, 1997), a common definition of airways obstruction would be desirable. From this point of view, the ATS document of 19915 and especially that of 19951 are helpful in so far as they have recommended the use of slow VC, ie, one of the essential factors to define airways obstruction according to the ERS criterion.2 Since the goal is to achieve a test that has a good sensitivity, specificity, predictive value, and overall accuracy, ad hoc clinical and epidemiologic studies might be needed.

The importance of the definition of airways obstruction is highlighted in the guidelines on COPD management issued by other scientific societies. The Canadian Thoracic Society27 did not provide any functional level to define airways obstruction, whereas the Thoracic Society of Australia and New Zealand28 reported two different figures for FEV1/VC (< 70%) and FEV1/FVC (< 75%). Finally, the British Thoracic Society29 required the presence of both a reduced FEV1 (< 80% predicted) and an FEV1/VC ratio of < 70% to diagnose airways obstruction. Even the graduation of COPD severity based on percent predicted FEV1 levels was different from those proposed by ATS and ERS.


    Conclusion
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Our findings show that the prevalence of COPD in a general population depends very much on the criterion used for airways obstruction definition, and that no existing criterion, neither recommended by scientific societies nor clinically chosen, is epidemiologically consistent. Thus, further research is needed to reach a common standardized and valid criterion for the definition of airways obstruction.


    Footnotes
 
Abbreviations: ATS = American Thoracic Society; ERS = European Respiratory Society; OR = odds ratio; VC = vital capacity

This study was supported in part by the Italian National Research Council, Targeted Project "Prevention and Control Disease Factors-SP 2" (Contract 91.00171.PF41), by Contract 587-1997 with Ministero del Lavoro e della Previdenza Sociale, and by an educational grant from Smithkline Beecham, Collegeville, PA.


    References
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 

  1. . American Thoracic Society. (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152,S77-S120
  2. Siafakas, NM, Vermeire, P, Pride, NB, et al (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 8,1398-1420[CrossRef][ISI][Medline]
  3. . World Health Organization. (1993) Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. ,95 National Institutes of Health Bethesda, MD.
  4. Desideri, M, Viegi, G, Carrozzi, L, et al (1997) Mortality rates for respiratory disorders in Italy (1979–1990). Monaldi Arch Chest Dis 52,212-216[Medline]
  5. . American Thoracic Society. (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144,1202-1218[ISI][Medline]
  6. . American Thoracic Society. (1986) Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 133,1205-1209[ISI][Medline]
  7. Lundbäck, B, Nystrom, L, Rosenhall, L, et al (1991) Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 4,257-266[Abstract]
  8. Viegi, G, Paoletti, P, Carrozzi, L, et al (1991) Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution. Environ Health Perspect 94,95-99[ISI][Medline]
  9. Manfreda, J, Mao, Y, Litven, W (1989) Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis 140,S19-S26
  10. Higgins, MW, Keller, JB (1989) Trends in COPD morbidity and mortality in Tecumseh, Michigan. Am Rev Respir Dis 140,S42-S48[ISI][Medline]
  11. Anthonisen, NR, Wright, EC, Hodgkin, JE (1986) Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133,14-20[ISI][Medline]
  12. Anthonisen, NR, Connett, JE, Kiley, JP, et al (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 272,1497-1505[Abstract]
  13. van Schayck, CP, van Grunsven, PM, Dekhuijzen, PNR (1996) Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J 9,1969-1972[CrossRef][ISI][Medline]
  14. Baldacci, S, Carrozzi, L, Viegi, G, et al (1997) Assessment of respiratory effect of air pollution: study design on general population samples. J Environ Pathol Toxicol Oncol 16,77-83[Medline]
  15. Carrozzi, L, Giuliano, G, Viegi, G, et al (1990) The Po River Delta epidemiological study of obstructive lung disease: sampling methods, environmental and population characteristics. Eur J Epidemiol 6,191-200[CrossRef][ISI][Medline]
  16. Viegi, G, Paoletti, P, Prediletto, R, et al (1988) Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1,311-318[Abstract]
  17. Paoletti, P, Pistelli, G, Fazzi, P, et al (1986) Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 22,451-459[ISI][Medline]
  18. Viegi, G, Carrozzi, L, Di Pede, F, et al (1994) Risk factors for chronic obstructive pulmonary disease in a North Italian rural area. Eur J Epidemiol 10,1-7
  19. Paoletti, P, Carrozzi, L, Viegi, G, et al (1995) Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking and level of pulmonary function. Am J Respir Crit Care Med 151,1770-1777[Abstract]
  20. Pistelli, G, Carmignani, G, Paoletti, P, et al (1987) Comparison of algorithms for determining the end-point of the forced vital capacity maneuver. Chest 91,100-105[Abstract/Free Full Text]
  21. . American Thoracic Society. (1987) Standardization of spirometry: 1987 update. Am Rev Respir Dis 136,1285-1298[ISI][Medline]
  22. Knapp, RG, Clinton Miller, M, III (1992) Clinical epidemiology and biostatistics. ,31-51 Harwal Publishing Company Malvern, PA.
  23. . American Thoracic Society. (1995) Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 152,1107-1136[ISI][Medline]
  24. US Public Health Service. The health consequences of smoking: chronic obstructive lung disease; a report of Surgeon General. Rockville, MD: Government Printing Office, 1984; DHHS Publ (PHS) 84–50205
  25. Lebowitz, MD (1989) The trends in airway obstructive disease morbidity in the Tucson Epidemiological Study. Am Rev Respir Dis 140(3 Pt 2),S35-S41[ISI][Medline]
  26. De Marco, R, Verlato, G, Zanolin, E, et al (1994) Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J 7,2139-2145[Abstract]
  27. . Canadian Thoracic Society. (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 147,420-428[Abstract]
  28. . Thoracic Society of Australia and New Zealand (1995) Guidelines for the management of chronic obstructive pulmonary disease. Mod Med Aust 38,132-146
  29. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease: the COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52:S1–28



This article has been cited by other articles:


Home page
ChestHome page
Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung
Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan
Chest, March 1, 2007; 131(3): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Pelkonen, I.-L. Notkola, A. Nissinen, H. Tukiainen, and H. Koskela
Thirty-Year Cumulative Incidence of Chronic Bronchitis and COPD in Relation to 30-Year Pulmonary Function and 40-Year Mortality: A Follow-up in Middle-Aged Rural Men.
Chest, October 1, 2006; 130(4): 1129 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. M. G. Halpin and M. Miravitlles
Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society
Proceedings of the ATS, September 1, 2006; 3(7): 619 - 623.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino
Global burden of COPD: systematic review and meta-analysis
Eur. Respir. J., September 1, 2006; 28(3): 523 - 532.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S. S. Hurd, Y. Fukuchi, C. K. W. Lai, P. X. Ran, F. W. S. Ko, S. M. Liu, et al.
Increasing COPD awareness.
Eur. Respir. J., April 1, 2006; 27(4): 833 - 852.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. Kim, Y. S. Kim, K.-S. Jung, J. H. Chang, C.-M. Lim, J. H. Lee, S.-T. Uh, J. J. Shim, W. J. Lew, and on behalf of the Korean Academy of Tuberculosis an
Prevalence of Chronic Obstructive Pulmonary Disease in Korea: A Population-based Spirometry Survey
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 842 - 847.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
R. M. Geijer, A. P. Sachs, A. W Hoes, P. L Salome, J.-W. J Lammers, and T. J. Verheij
Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old
Fam. Pract., October 1, 2005; 22(5): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
M. Lin, Y. Chen, and I. McDowell
Increased risk of depression in COPD patients with higher education and income
Chronic Respiratory Disease, January 1, 2005; 2(1): 13 - 19.
[Abstract] [PDF]


Home page
ChestHome page
C. Shin, S. Lee, R. D. Abbott, J. H. Kim, S. Y. Lee, K. H. In, and K. Kimm
Respiratory Symptoms and Undiagnosed Airflow Obstruction in Middle-Aged Adults: The Korean Health and Genome Study
Chest, October 1, 2004; 126(4): 1234 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. A. M. Kerstjens
The GOLD Classification Has Not Advanced Understanding of COPD
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 212 - 213.
[Full Text] [PDF]


Home page
ChestHome page
C. Shin, K. H. In, J. J. Shim, S. H. Yoo, K. H. Kang, M. Hong, and K. Choi
Prevalence and Correlates of Airway Obstruction in a Community-Based Sample of Adults
Chest, June 1, 2003; 123(6): 1924 - 1931.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S.T. Weiss, D.L. DeMeo, and D.S. Postma
COPD: problems in diagnosis and measurement
Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. J. Halbert, S. Isonaka, D. George, and A. Iqbal
Interpreting COPD Prevalence Estimates: What Is the True Burden of Disease?
Chest, May 1, 2003; 123(5): 1684 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. Lundback, A. Gulsvik, M. Albers, P. Bakke, E. Ronmark, G. van den Boom, J. Brogger, L-G. Larsson, I. Welle, C. van Weel, et al.
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Eur. Respir. J., May 1, 2003; 21(40_suppl): 3S - 9s.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Sandstrom, A.J. Frew, M. Svartengren, and G. Viegi
The need for a focus on air pollution research in the elderly
Eur. Respir. J., May 1, 2003; 21(40_suppl): 92S - 95s.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viegi, G.
Right arrow Articles by Giuntini, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viegi, G.
Right arrow Articles by Giuntini, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS